期刊文献+

人类免疫缺陷病毒和结核分枝杆菌合并感染治疗的进展 被引量:6

原文传递
导出
摘要 结核病是HIV感染者常见的机会性感染.2012年全球约13%的新发结核病患者同时为HIV感染者[1],HIV阳性的活动性结核患者或患有活动性结核的HIV感染者称为HIV/结核分枝杆菌(TB)合并感染者.HIV/TB合并感染者病情复杂、治疗棘手、病死率高,及时、有效、合理地进行抗结核治疗(anti-tuberculosis therapy,ATT)和抗反转录病毒治疗(antiretroviral therapy,ART)是降低病死率的关键[1-2].现就HIV/TB合并感染治疗的研究进展进行综述,重点阐述ATT和ART基本原则、ATT药物与ART药物相互作用、ATT药物与ART药物不良反应,以及结核相关性免疫重建炎性综合征(tuberculosis-associated immune reconstitution inflammatory syndrome,TB-IRIS).
出处 《中华传染病杂志》 CAS CSCD 北大核心 2015年第1期56-59,共4页 Chinese Journal of Infectious Diseases
基金 重庆市医学科研计划项目(2014-3-010)
  • 相关文献

参考文献25

  • 1World Health Organization. Global tuBerculosis report 2013[R/OL]. Geneva: WHO, 2013 [2014-02-28]. http://apps. who. int/iris/bitstream/10665/91355/1/9789241564656 _ eng. pdf.
  • 2《国家免费艾滋病抗病毒药物治疗手册》编写组.国家免费艾滋病抗病毒药物治疗手册[M].3版.北京:人民卫生出版社,2012:68-69.
  • 3Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV 1- Infected Adults and Adolescents [ M/OL]. Department of Health and Human Services, 2014. http://aidsinfo, nih. gov/ cont ent files/lvguidelines/aduhandadolescentgl, pdf.
  • 4Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV- infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America [J]. MMWR Recomm Rep, 2009,58(RR-4):1-207.
  • 5Naidoo K, Baxter C, Abdool Karim SS. When to start antiretroviral therapydurng tuberculoss treatment? [J]. Curr Opin Infect Dis, 2013,26(1):35-42.
  • 6Ahmad Khan F, Minion J, AILMotairi A, et al. An updated systematic review and recta-analysis on the treatment of active tuberculosis in patients with HIV infection [J]. Clin Infect Dis, 2012,55(8): 1154-1163.
  • 7Khan FA, Minion J, Pal M, et al. Treatment of active tuberculosis in HIV coinfected patients: a systematic review and meta analysis [J]. Clin Infect Dis, 2010, 50 (9): 1288- 1299.
  • 8Swaminathan S, Narendran G, Venkatesan P, et al. Efficacy of a 6-month versus 9 month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial [J]. Am J Respir Crit Care Med, 2010,181(7) :743-751.
  • 9Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy [J].N Engl J Med, 2010,362(8):697-706.
  • 10Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment [J]. N Engl J Med, 2011,365(16) :1492-1501.

共引文献1

同被引文献65

  • 1宋玉霞,艾尼瓦尔·吾拉木,宋国平,王艳,刘晓萱,杨彤彤,赵瑞阳.艾滋病相关型卡波西肉瘤消化道内镜特点[J].中国艾滋病性病,2020,0(2):165-167. 被引量:3
  • 2肖水源.《社会支持评定量表》的理论基础与研究应用[J].临床精神医学杂志,1994,4(2):98-100. 被引量:4093
  • 3Raghavan S,Alagarasu K,Selvaraj P.Immunogenetics of HIV and HIV associated tuberculosis[J].Tuberculosis ( Edinb ),2012,92(1):18-30.
  • 4Junling G,Pinpin Z.Hua F.Prevalence of TB/HIV Co-Infection in Countries Except China:A Systematic Review and Meta-Anal- ysis[J].Plos One,2013,8(5):e64915.
  • 5Rappuoli R,Aderem A.A 2020 vision for vaccines against HIV,tuberculosis and malaria[J].Nature,2011,473(7348):463-9.
  • 6Moir S,Chun T W,Fauci A S.Pathogenic mechanisms of HIV disease[J].Annu Rev Pathol,2011,6:223-8.
  • 7Raghavan S,Alagarasu K,Selvaraj P.Immunogenetics of HIV and HIV associated tuberculosis[J].Tuberculosis ( Edinb),2012,92(1):18-30.
  • 8Ramana RPV,Rajasekaran S,Raja A.Natural killer cell-media- ted cytokine response among HIV-positive south Indians with pul- monary tuberculosis[J].J Interferon Cytokine Res,2010,30(1):33-42.
  • 9夏宗平.艾滋病合并结核病的临床诊治分析[J].医学信息,2015,28(15):313.
  • 10Swaminathan S,Narendran G,Venkatesan P,et al.Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV- infected patients with tuberculosis:a randomized clinical trial[J].Am J Respir Crit Care Med,2010,181(7):743-51.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部